December 2021 l Screening Compliance Update
The Stay of the ETS
On Saturday, November 6, 2021, the United States Court of Appeals for the Fifth Circuit (“Fifth Circuit”) in B.S.T. Holdings, L.L.C. et al. v. Occupational Health and Safety Administration et al., No. 21-60845, granted the petitioners’ emergency motion to stay the enforcement of the ETS, citing to “grave statutory and constitutional issues with the Mandate.” The Fifth Circuit did not provide any further explanation of its specific concerns, notwithstanding its very conscious choice of the adjective “grave” in its very short, unpublished opinion. As part of the expedited judicial review of the ETS, the Fifth Circuit gave the government until the close of business on Monday, November 8, 2021, to file a response brief to the petitioners’ motion to stay and then gave the petitioners until the close of business on Tuesday, November 9, 2021, to file their reply brief. Presumably, the Fifth Circuit will then hold oral argument and issue an opinion that can then be the basis of an attempted appeal to the Supreme Court of the United States. In addition to the proceedings before the Fifth Circuit, other challenges are pending before the Sixth, Eighth, and Eleventh Circuits of Appeal. The proceedings before the Eighth Circuit were brought by a number of states (Missouri, Arizona, Nebraska, Montana, Arkansas, Iowa, North Dakota, South Dakota, Alaska, New Hampshire, and Wyoming) and private entities arguing that the ETS goes beyond workplace safety and into issues of general public health and, therefore exceeding OSHA’s scope of authority. The proceedings before the Sixth and Eleventh Circuits make similar challenges. Even with the stay issued by the Fifth Circuit, the other legal challenges should progress rapidly before the various courts so that arguments that may be raised before the Supreme Court are crystallized. Understanding that how these challenges may ultimately play out is still very much uncertain, the ETS, as drafted, required employers with 100 or more employees to achieve full vaccination status or implement mandatory testing for unvaccinated employees by January 4, 2022. With the stay of the ETS, it is unclear whether and when this mandate may come into effort, but employers still should consider planning for the contingency that the ETS will be effective at some point in the future, including as early as January 4, 2022.Who Is Covered by the ETS?
The ETS, as issued, applies to any employer that has 100 or more employees at any time while the ETS is effective. Notably, the threshold includes all employees, company or firm-wide, even if some of those employees are ultimately exempted from vaccine or testing due to individual circumstances, as discussed below. For example, an employer with 50 locations that each has only two employees would still be covered by this ETS. The threshold also includes any seasonal, temporary, and part-time employees but not any independent contractors. If an employer’s workforce fluctuates throughout the duration of the ETS, its provisions will apply to the employer during any period in which it has 100 or more employees.Are There Any Exceptions to Employer Coverage?
Certain employers who are covered by other federal vaccine and testing mandates are excluded from the new ETS. Specifically, employers that are subject to the Safer Federal Workforce Task Force COVID-19 Workplace Safety: Guidance for Federal Contractors and Subcontractors or healthcare providers that are subject to the Centers for Medicaid and Medicare Services (CMS) COVID-19 rule are not covered by the ETS.Are There Any Exceptions to Employee Coverage?
Although all employees count toward the 100-employee threshold, some employees are exempt from the ETS’ requirements even if their employer is covered. Namely, employees who: (1) do not report to a workplace where other individuals (either customers or co-workers) are present; (2) work from home; or (3) work exclusively outdoors are not subject to vaccination or testing requirements. However, if these individuals who, for example, work from home, do occasionally come into the office or interact with other individuals indoors, then they will be subject to the ETS’ requirements discussed below. Employees who have a disability or medical reason for refusing or delaying vaccination or who have sincerely held religious beliefs preventing vaccination are also still exempt from any vaccination requirement but are otherwise subject to testing and/or mask-wearing.I’m a Covered Employer. How Do I Comply With the ETS?
If the ETS is declared enforceable, covered employers will be required to develop and implement a policy for their employees that either (a) requires vaccination of all employees (subject to the limited exceptions); or (b) requires vaccination or weekly testing and face coverings. The ETS has four main requirements for employers: 1. Implement a Compliant Mandatory Vaccine or Vaccine/Testing Policy for Employees A covered employer’s first option for complying with the ETS is to implement a policy that requires all employees (other than those who are exempt because of, for example, a disability or religious accommodation) to be fully vaccinated. Fully vaccinated status is defined as receiving both doses of either the Moderna or Pfizer vaccine or a single dose of the Johnson & Johnson vaccine. OSHA has not yet determined whether fully vaccinated status will require any booster shots in the future. If employers do not want to adopt a mandatory vaccination policy, the ETS provides a second option for compliance: a vaccination/testing policy. If a covered employer chooses this option, the employer can give employees a choice between: (1) getting fully vaccinated; or (2) submitting to regular COVID-19 testing and wearing a face covering at the workplace. Importantly, employers can choose different policies for different portions of their workforce. For example, if a retail company has a customer-facing workforce and a portion of the workforce that works exclusively in offices, then the company could require mandatory vaccination for the customer-facing employees and give the vaccine/testing option to those employees who do not interact with customers. Regardless of which policy the employer chooses, employers must determine employees’ vaccination status by requesting proof from employees. Acceptable proof includes (a) the Centers for Disease Control and Prevention (“CDC”) vaccination card; (b) records of immunization from a healthcare provider, pharmacy, or public health immunization system; (c) medical record reflecting vaccination; (d) another official document that contains the required information; or (e) a signed attestation by an employee who cannot provide another form of proof. If an employer previously determined the vaccination status of its employees prior to November 5, 2021, the employer does not have to re-evaluate vaccination status, but must still maintain such records and determine the status of any new employees. If an employer chooses the vaccination/testing option, there are stringent requirements pertaining to the timing of the tests:- For employees who report at least once every seven days to a workplace where other individuals (co-workers or customers) are present, they must be tested at least once every seven days and must provide documentation of their most recent test no later than the seventh day after they last provided a result; and
- For employees who do not report at least once every seven days (i.e., those who work from home for extended periods of time), they must be tested within seven days before their return to the office and provide the results either prior to or upon their return to the office.
- The requirements of the ETS and the employer’s policies implemented in response;
- Information about the safety and efficacy of the COVID-19 vaccine provided by the CDC;
- The requirements of 29 CFR 1904.35(b)(1)(iv), which prohibit discrimination and retaliation under the Occupational Safety and Health Act; and
- The penalties under OSHA for knowingly providing false documentation (i.e., falsified vaccination records).
- Receiving a negative result on a confirmatory nucleic acid amplification test following a positive antigen test;
- Meeting the requirements for returning to work set out in the CDC’s “Isolation Guidance”; or
- Being authorized to return to work by a licensed healthcare provider.
What if an Employer’s State Government Has a Conflicting Law?
A number of states and other political subdivisions have passed laws or ordinances prohibiting employers from requiring vaccination, testing, or face coverings. Given the political realities of the ETS, OSHA included express language that the ETS preempts all state or local rules relating to face coverings, testing, or vaccinations in the workplace. Therefore, pursuant to the ETS, covered employers cannot prohibit the wearing of face coverings (by employees or customers) and must require testing or vaccination even if their state, city, or municipality says otherwise.Planning Ahead
Notwithstanding the Fifth Circuit’s stay, we recommend that employers who otherwise are covered by the ETS do two things: (1) continue to monitor pending proceedings, particularly those by the appellate courts with jurisdiction over their workforce; and (2) make conditional plans to comply with the ETS, knowing that it still could be effective, either as issued or as later modified by OSHA to address legal challenges. Read more from AGG. The Federal Contractor Vaccine Mandate Is “On Hold,” at Least in Kentucky, Ohio, and Tennessee On November 30, 2021, the United States District Court for the Eastern District of Kentucky in the lawsuit, Commonwealth of Kentucky et al. v. Joseph R. Biden et al., Civil Action No. 3:21-cv-00055-GFVT, granted a preliminary injunction enjoining the federal government from enforcing the federal contractor vaccine mandate, which has its genesis in Executive Order 14042 issued by President Biden on September 9, 2021 (“EO 14042”). The injunction applies to “all covered contracts in Kentucky, Ohio, and Tennessee.” The court acknowledged that “vaccines are effective” and “the government, at some level, and in some circumstances, can require citizens to obtain vaccines,” but determined that President Biden “exceeded his authority” under the Federal Property and Administrative Services Act in imposing EO 14042 on federal contractors and subcontractors. Moreover, the court entered a “permanent injunction,” stating, “Although the debate over the proper scope of injunctions is ongoing, this Court believes that redressability in the present case is properly limited to the parties before the Court. Consequently, the scope of the permanent injunction shall apply to Kentucky, Ohio, Tennessee and the additional sheriff plaintiffs before the Court in equal force.” Notwithstanding the label as “permanent” versus “preliminary,” the injunction will undoubtedly be appealed to the United States Court of Appeals for the Sixth Circuit, the same appellate court that is considering whether to continue the stay of OSHA’s Emergency Temporary Standard imposing mandatory vaccination/testing for most employees of employers with 100 or more employees. It is also unclear exactly how this injunction will be applied. Does this injunction mean that EO 14042 no longer applies to covered contracts that are being performed in Kentucky, Ohio, and Tennessee or to the employees in those three states employed by government contractors with “covered contracts” even if the work is being performed in other states? Does the injunction apply to a company with covered contracts based in one of those three states even if the company has employees working on those covered contracts who are living in one of the other 47 states? The details of applicability of the injunction of EO 14042 are currently unclear and could be subject to efforts to enlarge, modify, and/or vacate the injunction. Furthermore, there are preliminary injunction hearings scheduled in several other challenges to the federal contractor vaccine mandate over the next week, including before the United States District Court for the Southern District of Georgia (December 3, 2021) and the United States District Court for the Middle District of Florida (December 7, 2021). Like what happened with the CMS Mandate issued for healthcare providers and suppliers, it is possible that one of these courts will extend the injunction, including potentially on a nationwide basis. If and until that occurs, however, government contractors who touch states other than Kentucky, Ohio, and Tennessee still potentially face consequences if they do not comply with EO 14042 outside of these states. For all of these reasons, the permanent injunction issued by the Eastern District of Kentucky is only a chapter of the story as to whether federal contractors and those they do business with must ensure that their employees are vaccinated. Read more from AGG. Two Federal District Courts Tag Team to Enjoin CMS Vaccine Mandate Enforcement In the course of 24 hours, two federal district courts, one in Missouri and one in Louisiana, issued preliminary injunctions that prevent the Centers for Medicare and Medicaid Services (“CMS”) from implementing and enforcing its Omnibus COVID-19 Health Care Staff Vaccination Interim Final Rule (“IFR”) applicable to certain Medicare and Medicaid-certified providers and suppliers. The collective effect of these decisions is to temporarily enjoin the IFR on a nationwide basis, pending appeals to the Sixth and Eighth Circuits, which could be consolidated much like the litigation involving the OSHA Emergency Temporary Standard (“ETS”) vaccination/testing mandate that was stayed by the Fifth Circuit Court of Appeals. On November 29, 2021, Judge Matthew Schelp of the U.S. District Court for the Eastern District of Missouri issued a preliminary injunction against the IFR effective in 10 states.1 More specifically, Judge Schelp enjoined the IFR with respect to providers and suppliers affected by the mandate in Alaska, Arkansas, Iowa, Kansas, Missouri, Nebraska, New Hampshire, North Dakota, South Dakota, and Wyoming. Just as providers and suppliers were digesting the implications of the limited nature of this injunction, Judge Terry Doughty of the U.S. District Court for the Western District of Louisiana issued a preliminary injunction on November 30, 2021, that applies to all states other than the 10 states insulated by the Eastern District of Missouri’s preliminary injunction.2 Both judges concluded that the IFR likely exceeds the authority delegated by Congress to the Secretary of the U.S. Department of Health and Human Services and, by extension, to CMS. As a result, they determined that a preliminary injunction was necessary to preserve the status quo pending further appeals or until the cases can be heard on their merits. The IFR not only mandates that employees of the 21 types of providers and suppliers covered by the rule be fully vaccinated by January 4, 2022, or be granted a medical or religious exemption, the expansive definition of “staff” subject to the mandate captures students, trainees, volunteers, licensed practitioners, and individuals providing care, treatment, or other services to the patients, and/or facilities of such providers or suppliers under contract or other arrangements. Furthermore, the IFR does not include an alternative testing option as contained in the now-stayed OSHA ETS. The IFR’s reach has had providers and suppliers scrambling to implement compliant policies and procedures since it was published in the Federal Register on November 5, 2021. More importantly, providers and suppliers have raced to notify contractors and vendors, many of whom were unaware that the mandate would apply to their employees by extension, in order to work through the numerous legal and logistical challenges presented by the broad reach of the IFR. While the preliminary injunctions entered into this week take the initial pressure off with respect to an impending December 6, 2021, deadline for staff to receive at least the first dose of a COVID-19 vaccine or apply for an exemption, the ultimate fate of the IFR will be decided in the appellate courts. Although recent decisions have been skeptical of all forms of federal vaccine mandates, we recommend that Medicare and Medicaid certified providers and suppliers potentially covered by the IFR use the additional time provided by these injunctions to complete their preparations for compliance with the IFR in its present form and to be prepared to pivot depending on the outcome of the appellate process. Read more from AGG. Georgia Judge Enjoins Federal Contractor Vaccine Mandate in Every State in U.S. On December 7, 2021, R. Stan Baker, judge for the United States District Court for the Southern District of Georgia, enjoined enforcement of Executive Order 14042 (“EO 14042”) “in all covered contracts in any state or territory of the United States of America.” EO 14042 requires that contractors and subcontractors performing work on certain federal contracts ensure that their employees and others working in connection with the federal contracts are fully vaccinated against COVID-19. The plaintiffs included the States of Georgia, Alabama, Idaho, Kansas, South Carolina, Utah, and West Virginia; the governors of several of those states; various state agencies; the Associated Builders and Contractors, Inc. (“ABC”), a trade organization; and ABC’s Georgia chapter. In deciding in favor of the plaintiffs, the court cited the Kentucky v. Biden case, No. 3:21-cv-55, 2021 WL 5587446, at *9 (E.D. Ky, Nov. 30, 2021), which stated, “This case is not about whether vaccines are effective. They are.” The judge also acknowledged the “tragic toll that the COVID-19 pandemic has wrought throughout the nation and the globe.” But, despite those acknowledgements, the court stated: However, even in times of crisis, this Court must preserve the rule of law and ensure that all branches of government act within the bounds of their constitutionally granted authorities. Indeed, the United States Supreme Court has recognized that, while the public indisputably “has a strong interest in combating the spread of [COVID-19],” that interest does not permit the government to “act unlawfully even in pursuit of desirable ends.” The court concluded that the plaintiffs likely will succeed in their claim that President Biden exceeded the authority given to him by Congress through the Federal Property and Administrative Services Act in issuing EO 14042. On this point, the court stated, “While the Procurement Act explicitly and unquestionably bestows some authority upon the President, the Court is unconvinced, at this stage of the litigation, that it authorized him to direct the type of actions by agencies that are contained in EO 14042.” With respect to the irreparable injury requirement, the court concluded that “the time and effort spent on these measures [ensuring that employees are fully vaccinated] . . . constitute compliance costs resulting from EO 14042, which appear to be irreparable.” In addressing the balancing of the harms, the court stated in part: Enjoining EO 14042 would, essentially, do nothing more than maintain the status quo; entities will still be free to encourage their employees to get vaccinated, and the employees will still be free to choose to be vaccinated. In contrast, declining to issue a preliminary injunction would force Plaintiffs to comply with the mandate, requiring them to make decisions which would significantly alter their ability to perform federal contract work, which is critical to their operations. Finally, the court wrote two sentences in discussing the public interest as follows: For similar reasons, a stay is firmly in the public interest. From economic uncertainty to workplace strife, the mere specter of [EO 14042] has contributed to untold economic upheaval in recent months” and “the principles at stake when it comes to [EO 14042] are not reducible to dollars and cents.” Although the court could have limited the scope of the injunctive relief to these seven states, it decided not to do so. Instead, it concluded that in order to truly afford injunctive relief to the parties before it, an injunction with nationwide applicability was warranted. Thus, the Supreme Court of the United States will likely agree to hear the U.S. government’s appeal on an expedited basis. Read more from AGG. U.S. Supreme Court Set to Rule on Vaccine Mandates The United States Supreme Court announced Wednesday, December 23, that it will hear oral argument in two of the cases challenging the vaccine mandates. One case concerns the OSHA ETS rule for private employers with more than 100 employees and the other concerns the Centers for Medicare and Medicaid Services’ vaccine mandate covering certain healthcare facilities. It appears the Supreme Court has recognized the urgent need to provide businesses with clarity concerning compliance with these vaccine mandates. It is uncertain as to when the Supreme Court will issue its ruling after arguments, but surely the Supreme Court is mindful of OSHA’s January 10 date for issuing citations. Once the Supreme Court issues its ruling, it will be the final word on these specific rules which have vexed employers for months. Businesses should still begin preparations for implementation of whichever rule is applicable to them in the event the Supreme Court upholds the mandates. Read more from Lexology. Supreme Court to Hear Argument on OSHA and CMS Rules January 7 The Supreme Court has announced that, on January 7, 2022, it will hear oral argument on challenges to two of the Biden administration’s significant rules regarding COVID-19 vaccination and testing in the workplace: OSHA’s Emergency Temporary Standard (ETS) and the Centers for Medicare and Medicaid Services (CMS) interim final rule. The Supreme Court also made clear that it will not be taking any action with regards to those challenges before January 7, 2022, at the earliest. The CMS interim final rule is currently stayed in 25 states, and CMS has stated that it is delaying enforcement nationwide pending litigation developments. However, the stay of the OSHA ETS has been lifted so that the ETS is in effect, and OSHA has advised that it intends to begin enforcement of most ETS requirements on January 10, 2022. While the Supreme Court’s announcement confirms that it will decide whether to reinstate a stay of the OSHA rule, it is now certain that the Court will not do so before January 7, and we do not know how long it will take the Court to make a ruling after the January 7 hearing. As such, employers should strongly consider preparing to implement key ETS requirements on January 10, including adopting an ETS-compliant policy, providing paid leave for employees needing time off to be vaccinated, and requiring that unvaccinated employees wear a mask when indoors. Read more from Lexology. CDC Issues Guidance for Employers to Address Possible Marijuana Use by Drivers bulletin directed to employers with workers who drive as part of their jobs. The bulletin, “Marijuana Driving: How to Keep Your Fleet’s Drivers Safe,” recognizes that marijuana use is on the rise due to the explosion of medical and recreational marijuana laws passed in most states. Because “marijuana is the most frequently reported drug found in post-crash testing,” the CDC explained that employers should address the issue as part of their “workplace motor vehicle safety programs.” The CDC began with a discussion of the impact that THC (delta-9-tetrahydrocannabinol) has on users. THC is the psychoactive compound that affects parts of the brain that control movements, balance, coordination, memory, and judgment. Specifically, it can “impair coordination, distort perception, and lead to memory loss and difficulty in problem-solving.” With respect to the impact that THC has on individuals when they drive, “THC can slow reaction times and reduce the ability to make decisions.” In fact, according to the CDC, the risk of a motor vehicle crash increases after the driver uses marijuana. That said, however, the CDC recognizes that because THC can be detected in the body days or weeks after use, the actual impact the drug might have on the accident is not certain. What does the CDC recommend for employers with workers who drive as part of their duties?- Develop a comprehensive marijuana policy that accounts for current laws in each state where the employer operates, which prohibits employees from using or being under the influence of marijuana (or any illegal drug) while working.
- Consult with counsel experienced with state marijuana laws in developing a new or revising an existing drug policy.
- Outline the specifics of any required drug testing if mandated by the policy, including the conditions under which testing will occur (e.g., random, reasonable suspicion, post-accident, etc.), the threshold that will constitute impairment, and the consequences of a positive test result.
- Engage a Medical Review Officer to review and interpret THC drug tests.
- Warn drivers that cannabidiol (CBD) products are not regulated, which means that products labeled “THC-free” or “pure CBD” still might have THC in them, and that consumption of CBD products with high THC levels could result in a positive drug test.
- Provide resources to employees with drug problems.
- Educate drivers on the effects of marijuana and other drugs on safe driving and cognitive abilities and the details of the employer’s drug policy.
- Train managers and supervisors on policy requirements and best practices for recognizing and documenting signs of possible drug impairment.
The Department of Fair Employment and Housing Ramps Up Enforcement of California’s “Ban-the-Box” Law
The California Department of Fair Employment and Housing (“DFEH”) recently announced a new effort to identify and correct violations of the Fair Chance Act. The Fair Chance Act, which was enacted in January 2018 and is commonly known as California’s “ban-the-box” law, amended the Fair Employment and Housing Act (“FEHA”) to prohibit employers with five or more employees from directly or indirectly inquiring into, seeking the disclosure of, or considering an candidate’s conviction history (including questions on a job application) until after the candidate receives a conditional offer of employment. We previously summarized employers’ obligations under the Fair Chance Act here. Among its restrictions, the Fair Chance Act imposes limitations on the types of statements employers can make in job advertisements. The law prohibits employers from publicizing that they will not consider candidates with a criminal history. This includes, for example, advertisements stating, “No Felons” or “Must Have Clean Record.” These and similar statements violate the Fair Chance Act’s requirement that employers consider an candidate’s criminal history on an individual basis, as well as any mitigating information provided by the candidate. While the Fair Chance Act has been in place since January 2018, the DFEH (the agency charged with enforcing the Fair Chance Act) continues to identify non-compliant job advertisements and materials that employers have posted online. In fact, in a recent one-day review of online job advertisements using technology to conduct mass searches of online job advertisements, the DFEH found over 500 advertisements containing unlawful statements that the employer would not consider job candidates with a criminal record. The DFEH announced that it is documenting these violations and sending notices to the employers to remove the unlawful statements. The DFEH also released a Fair Chance Act Toolkit and plans to release an interactive training and online application in 2022 to assist employers with compliance. The toolkit provides the following resources:- Sample forms that employers can use to follow the Fair Chance Act’s required procedures;
- A guide to using DFEH’s sample forms;
- A suggested statement that employers can add to job advertisements and applications to let candidates know that the employer will consider individuals with criminal histories;
- Answers to frequently asked questions about the Fair Chance Act; and
- An informational video that explains the Fair Chance Act.
- Those younger than two years old;
- Those with a medical condition, mental health condition or disability that prevents them from wearing a mask. This includes persons with a medical condition for whom wearing a mask could obstruct breathing or who are unconscious, incapacitated or otherwise unable to remove a mask without assistance;
- Those who are hearing impaired, or must communicate with the hearing impaired where the ability to see the mouth is essential for communication; and
- Those for whom wearing a mask would create a workplace safety risk.
- The vaccine mandate applies to all New York City employers (regardless of size) that maintain a workplace in New York City.
- By December 27, 2021, all employees, interns, volunteers and independent contractors of covered employers who perform in-person work or interact with the public must show proof they have received at least one dose of a COVID-19 vaccine. Workers who have received the first dose of a double-dose vaccine by December 27 will then have 45 days to show proof of their second dose.
- The vaccine mandate does not apply to workers who: (1) work from home and whose employment does not involve interacting in-person with co-workers or members of the public; (2) enter a workplace briefly for a limited purpose; or (3) are non-New York City residents and performing artists or college or professional athletes (as well as those who are accompanying such individuals).
- Employers must verify and keep a record of each worker’s proof of vaccination by December 27. Employers may fulfill this requirement by: (1) maintaining a copy of the worker’s proof of vaccination (i.e., vaccine card); (2) creating a form that includes the worker’s name and vaccination status; or (3) checking each worker’s proof of vaccination each day they enter the workplace and keeping a record of such verification. For non-employee workers, including independent contractors, businesses may request that the worker’s employer confirm that the worker is vaccinated (and keep a record of such confirmation) instead of verifying proof of vaccination pursuant to the methods outlined above.
- Workers who have requested and been granted a reasonable accommodation for a medical or religious reason are not required to comply with the vaccine mandate. The guidance provides detailed information, forms and checklists to help employers evaluate requests for reasonable accommodations.
- Employers must also post a certificate in the workplace affirming they are in compliance with the vaccine mandate by December 27.
- Read more from Lexology.
- Any federal or state statute, regulation, or order that requires drug testing of prospective employees for purposes of safety or security.
- Any contract between the federal government and an employer or any grant of financial assistance from the federal government to an employer that requires drug testing of prospective employees as a condition of receiving the contract or grant.
- A collective bargaining agreement that specifically addresses pre-employment drug testing.
New York City Employers Will Be Required to Post Salary Ranges in Job Advertisements as of April 2022
Under a new law passed by the New York City Council, which will go into effect in April 2022 if not vetoed by January 14, 2022, employers in New York City will have to include the minimum and maximum starting salary for any “advertised job, promotion or transfer opportunity.” The bill, available here, will amend the New York City Human Rights Law (NYCHRL) to require that employers disclose a salary range “from the lowest to the highest salary the employer in good faith believes at the time of the posting it would pay for the advertised job, promotion or transfer opportunity” on all job advertisements for positions located in New York City. Employers will also have to include the salary range in all announcements or postings regarding promotion or transfer opportunities. As the term “salary” is not defined, employers should comply with the new law regardless of whether a position is a salaried, exempt, or hourly non-exempt position. Failure to include a salary range would be considered a discriminatory practice under the NYCHRL. The posting requirement will not apply to temporary positions listed by temporary help firms. The bill gives the New York City Commission on Human Rights (NYCCHR) the power to issue rules and regulations to implement and enforce the law. The NYCCHR is expected to clarify whether the salary range requirement applies to all jobs advertised in New York City, or only postings for jobs physically located in New York City. Mayor DeBlasio, or his successor, Mayor-elect Eric Adams, has until January 14, 2022, (30 days) to approve or veto the bill, which will go into effect in April 2022 even if the mayor does not affirmatively approve or deny the bill by January 14, 2022. The New York City law is part of a growing trend of wage transparency laws that have been enacted in other jurisdictions in an effort to promote wage equity for groups who have historically received lower compensation. So far, only Colorado’s law, like the recent New York City bill, requires employers to include salary ranges in job postings. Other laws require employers to provide wage information upon the candidate’s request or at other times during the recruitment process.- Laws in Maryland and Washington State require employers to disclose the pay range for a position upon an candidate’s request.
- In California, an candidate who has been interviewed for a position may request the pay range.
- In Nevada, employers must provide salary range information to any candidate who has been interviewed for a position, even absent a request.
- In Connecticut, employers must disclose the wage range upon the earlier of (i) the candidate’s request or (ii) when a job offer is made.
- Rhode Island enacted a similar law, scheduled to go into effect on January 1, 2023, which will require employers to provide candidates with the salary range for a position upon the earlier of the (i) candidate’s request, (ii) when inquiring about an candidate’s salary expectations, or (iii) when an offer is made.
- In Ohio, local laws in Toledo and Cincinnati require employers to provide the salary scale for a position if an candidate who has received a conditional offer requests the information.
Prime Minister Boris Johnson has announced a move to Plan B in England.
What are the changes? A full list of guidance on these changes will be available on gov.uk in the coming days, but the key points published to date are as follows:- From Friday 10 December, face coverings will be compulsory in most public indoor venues, such as cinemas, theatres and places of worship, unless it is not practical to wear one. Face masks will not be required in hospitality settings.
- From Monday 13 December, those who can will be advised to work from home.
- From Wednesday 15 December, and subject to parliamentary approval, the NHS COVID Pass (showing a negative lateral flow test or full vaccination) via the NHS App will be mandatory for entry into nightclubs and settings where large crowds gather. This includes unseated indoor events with 500 or more attendees, unseated outdoor events with 4,000 or more attendees and any event with 10,000 or more attendees.
- Communication is key. Talk to your employees to understand whether they still feel comfortable attending.
- Continue to be inclusive.Try not to exclude anyone who does not feel comfortable physically taking part in your Christmas party. Consider offering them the chance to attend virtually.
- Be clear with what you expect.Send out clear communications to ensure your employees understand what the expected standards of behaviour are. Consider what measures you will have in place that employees will need to abide by.
- Know your duties as an employer.As an employer you owe a duty of care to provide a safe working environment. Consider requiring a negative lateral flow test beforehand and ensuring sufficient ventilation.
- Read more from Lexology.
Let's start a conversation
At ClearStar, we are committed to your success. An important part of your employment screening program involves compliance with various laws and regulations, which is why we are providing information regarding screening requirements in certain countries, region, etc. While we are happy to provide you with this information, it is your responsibility to comply with applicable laws and to understand how such information pertains to your employment screening program. The foregoing information is not offered as legal advice but is instead offered for informational purposes. ClearStar is not a law firm and does not offer legal advice and this communication does not form an attorney client relationship. The foregoing information is therefore not intended as a substitute for the legal advice of a lawyer knowledgeable of the user’s individual circumstances or to provide legal advice. ClearStar makes no assurances regarding the accuracy, completeness, or utility of the information contained in this publication. Legislative, regulatory and case law developments regularly impact on general research and this area is evolving rapidly. ClearStar expressly disclaim any warranties or responsibility or damages associated with or arising out of the information provided herein.